The Supervisory Board of Röhm GmbH has appointed Dr. Hans Bohnen as Managing Director of Röhm GmbH effective February 1, 2024. Dr. Hans Bohnen is taking over the CEO role from Dr. Michael Pack, who decided after 34 successful years in the chemical industry and almost ten years at the top of the MMA/PMMA business to withdraw from the operational business and retire as of March 1, 2024.
Ronald Ayles, Managing Partner at Advent International said, “We would like to express our sincere gratitude to Michael Pack. As the CEO, he has had a decisive impact on building and continuously developing the new company Röhm while also implementing the growth strategy in a determined and team-oriented manner”.
Dr. Dahai Yu, Chairman of the Röhm Supervisory Board added, “Michael Pack successfully led the company through the pandemic and drove key projects such as the construction of the new LiMA plant and the acquisition of the functional forms business from SABIC. We very much regret his decision to retire and wish him all the best for the future”.
The press release stated that the change of leadership at the top of Röhm has been planned long-term and will take place seamlessly during the first quarter with a joint handover period for the top management. “Röhm has the target to become the world’s leading Methacrylate-Verbund and aims to further expand the company’s technological leadership position. I will play an active role in shaping this,” said Hans Bohnen.
Ayles further stated, “With Dr. Hans Bohnen, we are gaining a proven industry expert who brings international experience from various chemical companies to the new role and brings comprehensive know-how of the respective market, technology and strategy”.
